| Elisabeth U Dexter, MD | |
|
Elm And Carlton Streets, Buffalo, NY 14263-0001 | |
| (716) 845-2300 | |
| (716) 845-7692 |
| Full Name | Elisabeth U Dexter |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 34 Years |
| Location | Elm And Carlton Streets, Buffalo, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427007095 | NPI | - | NPPES |
| 02298617 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 224564 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaleida Health | Buffalo, NY | Hospital |
| Mount St. Mary's Hospital & Health Center | Lewiston, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roswell Park Cancer Institute | 3577475110 | 432 |
| Rpci Oncology, Pc | 3870731029 | 44 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.
Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors.
Domestic violence survivors commonly suffer repeated blows to the head and strangulation, trauma that has lasting effects that should be widely recognized by advocates, health care providers, law enforcement and others who are in a position to help, according to the authors of a new study.
› Verified 4 days ago
| Entity Name | Roswell Park Cancer Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720036593 PECOS PAC ID: 3577475110 Enrollment ID: O20031103000466 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.
Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors.
Domestic violence survivors commonly suffer repeated blows to the head and strangulation, trauma that has lasting effects that should be widely recognized by advocates, health care providers, law enforcement and others who are in a position to help, according to the authors of a new study.
› Verified 4 days ago
| Entity Name | Rpci Oncology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952703985 PECOS PAC ID: 3870731029 Enrollment ID: O20130529000409 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.
Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors.
Domestic violence survivors commonly suffer repeated blows to the head and strangulation, trauma that has lasting effects that should be widely recognized by advocates, health care providers, law enforcement and others who are in a position to help, according to the authors of a new study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elisabeth U Dexter, MD Elm And Carlton St, Buffalo, NY 14263-0001 Ph: (716) 845-2300 | Elisabeth U Dexter, MD Elm And Carlton Streets, Buffalo, NY 14263-0001 Ph: (716) 845-2300 |
News Archive
Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:
New research reveals rising rates of liver cancer around the world, despite advances aimed at preventing the disease. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.
Obsessive-compulsive disorder tends to run in families, causing members of several generations to experience severe anxiety and disturbing thoughts that they ease by repeating certain behaviors.
Domestic violence survivors commonly suffer repeated blows to the head and strangulation, trauma that has lasting effects that should be widely recognized by advocates, health care providers, law enforcement and others who are in a position to help, according to the authors of a new study.
› Verified 4 days ago
Dr. Thamer Robert Qaqish, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-3948 Fax: 716-961-6969 | |
Stephen W Downing, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 515 Abbott Rd, Suite 310, Buffalo, NY 14220 Phone: 716-923-9650 Fax: 716-961-4440 | |
Dr. Eddie Lee Hoover, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3495 Bailey Ave, Buffalo, NY 14215 Phone: 716-834-9200 Fax: 716-862-8600 | |
Mark W Hennon, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Cancer Center Ground Floor, Buffalo, NY 14263 Phone: 716-845-2300 | |
Chukwumere Nwogu, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-7692 | |
Mr. Daniel Zayac, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-5111 Fax: 716-898-5324 | |
Mr. Mohammad H Ashraf, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 10 High Street, C3, Buffalo, NY 14203 Phone: 716-859-7600 Fax: 716-859-2885 |